Cargando…

Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study

INTRODUCTION: This study aimed to demonstrate the beneficial effect of lixisenatide as add-on therapy to oral antidiabetics (OADs) in type 2 diabetes mellitus (T2DM) patients in routine clinical practice in Bulgaria. METHODS: This was a prospective, observational, multicentre study evaluating the re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Temelkova, Nataliya, Vladeva, Stefka, Delchev, Aleksi, Ivanova, Kalina, Gerasimova-Zheleva, Yoanna, Kuneva, Tsvetodara, Pehlivanova, Veselina, Popivanov, Plamen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531544/ https://www.ncbi.nlm.nih.gov/pubmed/30919317 http://dx.doi.org/10.1007/s13300-019-0603-9

Ejemplares similares

Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study
por: Kamenov, Zdravko, et al.
Publicado: (2021)

Lixisenatide as add-on therapy to basal insulin
por: Brown, Dominique Xavier, et al.
Publicado: (2013)

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
por: Ericsson, Åsa, et al.
Publicado: (2018)

Lixisenatide as add‐on treatment among patients with different β‐cell function levels as assessed by HOMA‐β index
por: Bonadonna, Riccardo C., et al.
Publicado: (2017)

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
por: Kirilova, E., et al.
Publicado: (2020)

Radical scavenging and antioxidant activities of methanolic extracts from Hypericum species growing in Bulgaria
por: Zheleva-Dimitrova, Dimitrina, et al.
Publicado: (2010)

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus
por: Fournier, Marie, et al.
Publicado: (2014)

Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study
por: Dailey, George E., et al.
Publicado: (2019)

Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria
por: Boyanov, Mihail A., et al.
Publicado: (2021)

Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
por: Yao, Jun, et al.
Publicado: (2023)

Students’ Attitudes toward COVID-19 Vaccination: An Inter-University Study from Bulgaria
por: Moskova, Martina, et al.
Publicado: (2022)

Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open‐label, multicenter study
por: Seino, Yutaka, et al.
Publicado: (2017)

Survey Study among Dentist in Bulgaria to Develop a Model for Risk Management in Dental Practice
por: Schiller, Tihomira, et al.
Publicado: (2022)

Detection of measles virus in Bulgaria from to 2018
por: Krumova, Stefka, et al.
Publicado: (2022)

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
por: Watada, Hirotaka, et al.
Publicado: (2020)

Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
por: Filipova, Elena Pavlova, et al.
Publicado: (2015)

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
por: Whyte, Martin B, et al.
Publicado: (2018)

Bulgaria /
Publicado: (2004)

Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis
por: Shu, Hua, et al.
Publicado: (2016)

Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone
por: Trujillo, Jennifer M., et al.
Publicado: (2018)

Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
por: Stankova, Teodora, et al.
Publicado: (2019)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018)

Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis
por: Men, Peng, et al.
Publicado: (2020)

Risk Assessment of Essential and Toxic Elements in Freshwater Fish Species from Lakes near Black Sea, Bulgaria
por: Peycheva, Katya, et al.
Publicado: (2022)

Ikoni ot Bulgaria = Icons in Bulgaria /
Publicado: (1975)

Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials
por: Eto, Kazuhiro, et al.
Publicado: (2015)

Bulgaria and CERN
Publicado: (1998)

Thysanoptera of Bulgaria
por: Karadjova, Olia, et al.
Publicado: (2015)

With the Wounded in Bulgaria
Publicado: (1913)

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients
por: Ballav, Chitrabhanu, et al.
Publicado: (2020)

Trace Elements and Omega-3 Fatty Acids of Wild and Farmed Mussels (Mytilus galloprovincialis) Consumed in Bulgaria: Human Health Risks
por: Peycheva, Katya, et al.
Publicado: (2021)

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
por: Becker, Reinhard H. A., et al.
Publicado: (2015)

Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL)
por: Kaneto, Hideaki, et al.
Publicado: (2022)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Changing the system of psychiatric care in bulgaria. Recover-E project in bulgaria
por: Nakov, V.
Publicado: (2021)

Bulgaria : el país de las rosas
por: Saldaña, Excilia, 1946-1999

Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients
por: Huyen, V. T. T., et al.
Publicado: (2012)

Q fever in Bulgaria: Laboratory and epidemiological findings on human cases and outbreaks, 2011 to 2017
por: Genova-Kalou, Petia, et al.
Publicado: (2019)

Iconos de Bulgaria.
Publicado: (1978)

Historia de Bulgaria /
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_c4vrccgl8ogqo4jm9b010d67vu